Remove Drug Development Remove Pharma R&D Remove Production
article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance.

article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

Want to know if your AI-identified tweaks to the productivity of your chemical plant do indeed improve output? Does AI improve decision making in drug R&D? AI in drug discovery and development is here to stay. Want to know if your large language model is providing convincing human-like output?

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

In 2022, the European Medicines Agency (EMA) provided a qualification opinion allowing the use of AI models to develop predicted control outcomes for Phase II/III trials from historical control data, ultimately requiring fewer participants to make this difficult randomisation choice.